Skip to main content
OpenTrials
Completed

NCT Number: NCT02936674

Color-dependent Melatonin Suppression

The purpose of this study is to examine the effects of complex, broad-band spectra light on the production of melatonin in humans.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

VA Palo Alto Health Care System

Palo Alto, California, 94304, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stable health
  • Normal color vision
  • Normal hearing
  • 18-35 years old

Exclusion criteria

  • Significant depressive symptoms
  • Pregnant or nursing
  • Ocular pathologies
  • Unstable or severe medical or psychiatric condition
  • Extreme morning/evening type
  • Regular smoker
  • Use of medications that impact ocular function
  • Alcohol use disorder
  • Use of illegal drugs
  • Irregular use of antihistamines, antidepressants, or sleeping medications

Treatment and study plan

Light - standard

Device

Light will be given during the night to determine its effects on melatonin suppression. This light will be an LED with standard spectral distribution

Light - alternate

Device

Light will be given during the night to determine its effects on melatonin suppression. This light will be an LED with an altered spectral distribution (different color)

Primary outcomes

  1. Melatonin suppression

    Time frame: 4 Hours

    The amount of declination of salivary melatonin concentrations between the start of the light and the end of the light (4 hours later) will be compared between the conditions.

Sponsors and collaborators

Lead sponsor

VA Palo Alto Health Care System

Fed

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Oct 18, 2016
Registry last updated
Jan 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.